Highlighted text has been updated as of October 11, 2024. The EAST-AFNET 4 trial showed that a rhythm-control strategy is superior to usual care in improving cardiovascular (CV) outcomes at 5 years ...
Mercury Marine’s recent foray into the electric-outboard market began with the Avator 7.5e, but as promised, both a higher-powered Avator 20e and 35e have now joined the lineup. Offering power ...
Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control ...
Earlier tissue plasminogen activator treatment improves ischemic stroke outcome, but aspects of the time-benefit relationship still not well delineated are: (1) the degree of additional benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results